News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
749,595 Results
Type
Article (47383)
Company Profile (293)
Press Release (701905)
Multimedia
Podcasts (110)
Webinars (20)
Section
Business (207437)
Career Advice (2209)
Deals (35920)
Drug Delivery (137)
Drug Development (83280)
Employer Resources (178)
FDA (16777)
Job Trends (15204)
News (352090)
Policy (33587)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2759)
Accelerated approval (55)
ADA (45)
Adcomms (30)
Allergies (193)
Alliances (50580)
ALS (232)
Alzheimer's disease (1870)
Antibody-drug conjugate (ADC) (523)
Approvals (17228)
Artificial intelligence (759)
ASCO (334)
Autoimmune disease (346)
Automation (64)
Bankruptcy (369)
Best Places to Work (11791)
BIO (67)
BIOSECURE Act (20)
Biosimilars (236)
Biotechnology (193)
Bladder cancer (205)
Brain cancer (76)
Breast cancer (809)
Cancer (6344)
Cardiovascular disease (510)
Career advice (1873)
Career pathing (46)
CAR-T (361)
CDC (70)
Celiac Disease (3)
Cell therapy (978)
Cervical cancer (58)
Clinical research (72584)
Collaboration (2259)
Commercialization (1)
Company closure (6)
Compensation (1489)
Complete response letters (84)
COVID-19 (2873)
CRISPR (119)
C-suite (1237)
Cystic fibrosis (158)
Data (8689)
Decentralized trials (3)
Denatured (33)
Depression (174)
Dermatology (97)
Diabetes (667)
Diagnostics (7110)
Digital health (64)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (370)
Drug pricing (206)
Drug shortages (32)
Duchenne muscular dystrophy (304)
Earnings (92649)
Editorial (72)
Employer branding (22)
Employer resources (157)
Events (122192)
Executive appointments (1136)
FDA (20801)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (35)
Funding (1882)
Gene editing (252)
Generative AI (65)
Gene therapy (764)
GLP-1 (1112)
Government (4973)
Grass and pollen (6)
Guidances (419)
Healthcare (19459)
Hematology (192)
HIV (90)
Huntington's disease (62)
IgA nephropathy (110)
Immunology and inflammation (312)
Immuno-oncology (104)
Indications (215)
Infectious disease (3255)
Inflammatory bowel disease (227)
Inflation Reduction Act (14)
Influenza (149)
Intellectual property (318)
Interviews (355)
IPO (16797)
IRA (52)
Job creations (3709)
Job search strategy (1550)
JPM (60)
Kidney cancer (20)
Labor market (112)
Layoffs (596)
Leadership (45)
Legal (8096)
Liver cancer (105)
Longevity (38)
Lung cancer (838)
Lymphoma (475)
Machine learning (68)
Management (62)
Manufacturing (1155)
Marketing (3)
MASH (210)
Medical affairs (1)
Medical device (14119)
Medtech (14288)
Mergers & acquisitions (20418)
Metabolic disorders (1660)
mRNA (242)
Multiple sclerosis (202)
NASH (18)
Neurodegenerative disease (462)
Neuropsychiatric disorders (111)
Neuroscience (3524)
Neurotech (1)
NextGen: Class of 2026 (6661)
Non-profit (4653)
Now hiring (82)
Obesity (766)
Opinion (310)
Ovarian cancer (239)
Pain (268)
Pancreatic cancer (353)
Parkinson's disease (397)
Partnered (35)
Patents (637)
Patient recruitment (772)
Peanut (66)
People (60728)
Pharmaceutical (62)
Pharmacy benefit managers (35)
Phase 1 (22893)
Phase 2 (31902)
Phase 3 (23644)
Pipeline (9827)
Policy (351)
Postmarket research (2608)
Preclinical (9886)
Press Release (68)
Prostate cancer (339)
Psychedelics (58)
Radiopharmaceuticals (346)
Rare diseases (1183)
Real estate (6046)
Recruiting (72)
Regulatory (26377)
Reports (57)
Research institute (2555)
Resumes & cover letters (388)
Rett syndrome (44)
RNA editing (26)
RSV (92)
Schizophrenia (182)
Series A (321)
Series B (238)
Service/supplier (11)
Sickle cell disease (124)
Special edition (24)
Spinal muscular atrophy (176)
Sponsored (49)
Startups (3751)
State (2)
Stomach cancer (18)
Supply chain (135)
Tariffs (89)
The Weekly (75)
Vaccines (1195)
Venture capital (122)
Weight loss (486)
Women's health (139)
Worklife (21)
Date
Today (28)
Last 7 days (443)
Last 30 days (2402)
Last 365 days (30576)
2026 (16122)
2025 (30598)
2024 (35689)
2023 (40577)
2022 (51812)
2021 (56313)
2020 (54813)
2019 (47271)
2018 (35638)
2017 (32727)
2016 (32301)
2015 (38282)
2014 (32055)
2013 (27364)
2012 (29430)
2011 (30043)
2010 (28013)
Location
Africa (802)
Alabama (94)
Alaska (7)
Arizona (371)
Arkansas (15)
Asia (41317)
Australia (6919)
California (14066)
Canada (3954)
China (1513)
Colorado (598)
Connecticut (615)
Delaware (434)
Europe (90224)
Florida (2111)
Georgia (448)
Hawaii (4)
Idaho (64)
Illinois (1153)
India (96)
Indiana (637)
Iowa (25)
Japan (599)
Kansas (135)
Kentucky (53)
Louisiana (61)
Maine (76)
Maryland (1680)
Massachusetts (10157)
Michigan (393)
Minnesota (765)
Mississippi (6)
Missouri (149)
Montana (37)
Nebraska (30)
Nevada (150)
New Hampshire (86)
New Jersey (3684)
New Mexico (32)
New York (3700)
North Carolina (1777)
North Dakota (10)
Northern California (7097)
Ohio (421)
Oklahoma (23)
Oregon (42)
Pennsylvania (2791)
Puerto Rico (31)
Rhode Island (52)
South America (1155)
South Carolina (87)
South Dakota (2)
Southern California (5567)
Tennessee (228)
Texas (2261)
United States (49735)
Utah (417)
Vermont (2)
Virginia (356)
Washington D.C. (83)
Washington State (1119)
West Virginia (4)
Wisconsin (139)
Wyoming (2)
749,595 Results for "human longevity inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Insilico Medicine and Human Longevity Announce Collaboration to Co-Develop Industry-First AI Foundation Model for Longevity Science
May 26, 2026
·
5 min read
Press Releases
Wellness Index Report Highlights Shift from Longevity to Root-Cause Health and Human Potential
June 3, 2026
·
1 min read
Press Releases
Greenstone Biosciences, Inc. and Intel Corp. Launch Strategic Collaboration to Scale Human-Centric Drug Discovery.
Combining human iPSC biology and AI computing to accelerate drug discovery, improve drug safety, and advance precision medicine.
June 19, 2026
·
1 min read
Press Releases
Rapalogix Health Raises $20 Million in Series A Financing to Redefine the Future of Longevity-Based Skin Health
June 23, 2026
·
5 min read
Insights
Beyond Buzzwords in Longevity Investing
In this episode of Denatured, you’ll listen to Sergey Jakimov, managing partner at LongeVC and Artem Trotsyuk, operating partner, US, LongeVC. We speak about how developers in the longevity space should stop chasing aging as an abstract target and concentrate on specific mechanisms that can clearly tackle age-related conditions.
March 26, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Press Releases
Yellowbird Diagnostics Completes Dosing in First-in-Human Phase 1 Trial of NeuCaVis(TM)
Human data demonstrates translation of key findings from preclinical studies
June 22, 2026
·
2 min read
Funding
NewLimit snags $435M after seeing age reversal in human liver cells
NewLimit is pressing the gas, speeding into clinical trials much sooner than expected after lab research showed its epigenetic reprogramming asset reversed aging in human liver cells.
June 3, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Allosteric Bioscience, Inc. Targets Extending Longevity
March 5, 2026
·
1 min read
Insights
Validated Mechanisms, Strong Data Beat Hype in Longevity Investing
Longevity is a long-standing buzzword in life sciences, but it now has staying power. The smart trajectory is to stop chasing aging as an abstract target and concentrate on specific mechanisms that can clearly target specific, age-related diseases, according to two investors in a discussion with
BioSpace.
March 23, 2026
·
3 min read
·
Jennifer C. Smith-Parker
Press Releases
Takara Bio USA, Inc. to Showcase Instrument-Free Approach to Spatial Biology at Human Cell Atlas 2026 Meeting
June 16, 2026
·
4 min read
1 of 74,960
Next
